Submit Deal

Announced

17 Jan 2023

Eris Lifesciences to acquire nine dermatology brands of Glenmark Pharmaceuticals for $42m.

Synopsis

Eris Lifesciences, a pharmaceutical company, agreed to acquire nine dermatology brands of Glenmark Pharmaceuticals, a pharmaceutical company, for $42m.

Principals

target

Glenmark Pharmaceuticals (nine Dermatology Brands)

bidder

Eris Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (6)

amit bakshi

Chairman and Managing Director at ERIS LIFESCIENCES

Manager

bidder

Deals

£ 248 M

Total Value

kalpana unadkat

Partner at Khaitan & Co

Lawyer

bidder

Deals

£ 1.58 B

Total Value

aman anand

Senior Associate at Khaitan & Co

Lawyer

bidder

Deals

£ 5.80 B

Total Value

ahaan dar

Associate at Khaitan & Co

Lawyer

bidder

Deals

£ 1.15 B

Total Value

arindam ghosh

Partner at Khaitan & Co

Lawyer

bidder

Deals

£ 6.14 B

Total Value

shailendra bhandare

Partner at Khaitan & Co

Lawyer

bidder

127

Deals

£ 19.71 B

Total Value

Vendor Team (1)

glenn mario saldanha

CEO at GLENMARK PHARMACEUTICALS

Manager

vendor

Deals

£ 626 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy